Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based model
A prognostic model was developed that can identify patients who are at high risk of early mortality during and after CRT. These patients may be included in clinical trials aiming to improve their outcome.
Authors
- Lizza Hendriks (ORCID: https://orcid.org/0000-0002-3521-2535)
- Juliette Degens (ORCID: https://orcid.org/0000-0003-0279-9656)
- Rianne D.W. Vaes (ORCID: https://orcid.org/0000-0001-6812-2897)
- Francesco Cortiula (ORCID: https://orcid.org/0000-0002-2719-3653)
- Dirk De Ruysscher (ORCID: https://orcid.org/0000-0001-9269-6567)
- Ruud Houben (ORCID: https://orcid.org/0000-0001-6869-9733)
- T. Jeroen N. Hiltermann (ORCID: https://orcid.org/0000-0002-0665-2160)
- Shaowen Lyu
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- Zuyderland Medisch Centrum (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108541
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00